4D Flow MRI Blood Flow Analysis Software Enhances Cardiovascular Diagnostic Accuracy
By MedImaging International staff writers Posted on 20 Jun 2023 |
Technological advancements, coupled with the progression of CT/MRI, have enabled the acquisition of more detailed information regarding blood flow within the body. Cardiac magnetic imaging research has revealed the evolving potential of advanced intracardiac flow analysis in heart disease, surpassing conventional measurements. Now, an innovative software solution that analyzes blood flow using 4D Flow MRI data has the potential to improve diagnostic accuracy for patients suffering from cardiovascular diseases and heart conditions.
The iTFlow software solution developed by Cardio Flow Design Inc. (Tokyo, Japan) aids in the analysis and evaluation of blood flow, primarily serving the cardiovascular surgery and radiology sectors. By utilizing MRI data, users can carry out their independent analysis and visualization of blood flow. The software facilitates visualization of fluid dynamics in the heart and blood vessels in 2D and 3D, even without the use of contrast agents.
Additionally, it allows for various quantitative evaluations, including the calculation of flow rate, velocity, pathline, streamline, and other parameters. By integrating sophisticated algorithms and image analysis techniques, iTFlow assists physicians and healthcare professionals in diagnosis and treatment planning. The US Food and Drug Administration has approved its use in blood flow analysis, equipping healthcare professionals with a more precise and effective tool for patient care decisions.
“We developed this software with the aim of enabling all physicians, regardless of their level of experience, to propose the most appropriate treatment for patients even with complicated anatomy and cardiac function by quantitatively evaluating blood flow,” said Dr. Itatani, MD, Ph.D., a cardiovascular surgeon specializing in adult congenital heart disease and the inventor of iTFlow.
“We are delighted this software has obtained FDA approval. We have been pursuing the concept of blood flow analysis with 4D flow MRI for many years, and iTFlow encapsulates the essence of this concept,” added company CEO, Teruyasu Nishino, MD. “With this approval, we believe that healthcare professionals will be able to provide more accurate diagnoses and treatment plans for cardiovascular diseases, especially for children with congenital heart disease, and will save many lives. This innovation will change the way of diagnosis and serve as a catalyst to spread the adoption of blood flow analysis worldwide.”
Related Links:
Cardio Flow Design Inc.
Latest MRI News
- Non-Invasive Medical Imaging Test Predicts Dementia Nine Years before Diagnosis
- Self-Powered Sensor to Make MRIs More Efficient
- Low-Level Light Therapy Heals Serious Brain Injuries
- New AI Tool Detects Possible Metastatic Breast Cancer by Improving MRI Sensitivity
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects